Our research
Our clinicians and researchers are involved in all stages and aspects of discovery, trials, therapies and treatments across all paediatric cancers.
Molecular Oncology
Professor Norris鈥檚 group utilises molecular genetic techniques to improve the diagnosis and risk classification of childhood cancers including leukaemia and neuroblastoma. A major area within the group is the use of functional genomics and high-throughput screening strategies to detect novel molecular targets and relevant inhibitors.
Contact: Professor Murray Norris
Leukaemia Biology
Leukaemia accounts for approximately one third of all paediatric malignancies and represents one of the most frequent causes of cancer-related deaths in children. The long-term goal of this group is to improve the treatment of children with leukaemia through the development of new therapies and their preclinical testing in clinically relevant experimental models.
Contact: Professor Richard Lock
Tumour Biology and Targeting
Dr Merlot leads a project in this group focused on (1) identifying drivers that cause resistance to cancer therapy, particularly the endoplasmic reticulum pathways; (2) understanding how the tumour microenvironment supports and protects cancer cells; and (3) developing and validating novel targets, drugs and drug delivery systems to treat the deadliest cancers, including pancreatic and brain cancer.
Contact: Dr Angelica Merlot
Contact us
For general enquiries and membership:
Dr Amanda Philp
Researcher Development & Strategy Manager
(02) 7209 6746